Coronavirus: Chinese vaccine could be ready by year-end, government body says
A Chinese-made coronavirus vaccine could be ready for market as early as the end of this year, China’s State-owned Assets Supervision and Administration Commission (SASAC) said in a social media post.
In trials, more than 2,000 people have received vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products. A vaccine could be ready for the market as early as the end of this year or early 2021, according to the May 29 post on Chinese social media platform WeChat.
Vaccines from the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products had entered Phase II clinical trials. Both groups are affiliated with state-owned pharmaceutical group Sinopharm, whose management is overseen by SASAC.
The Beijing Institute of Biological Products’ production line will have an annual manufacturing capacity of 100 million to 120 million doses, according to the article.
China has five coronavirus vaccines in human trials. Neither company could be reached for comment on Saturday evening.
Coronavirus: China vows to make COVID-19 vaccine a ‘global public good’ once readyChina would make any coronavirus vaccine it developed a “global public good” once it was put into use, President Xi Jinping told the World Health ... Coronavirus
Coronavirus: Fifth vaccine in human trials phase in China, says officialChina has a fifth potential coronavirus vaccine in a human trial and more are on the way, a health official said Friday, as the world races to find a ... Coronavirus
Coronavirus: China approves clinical trial for two experimental vaccinesChina has approved early-stage human tests for two experimental vaccines to combat the new coronavirus that killed over 100,000 people worldwide, ... Coronavirus